P. J. Kappelle

Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity

R. Dullaart, G. Dallinga-Thie, R. Dullaart, 2012, Journal of internal medicine.

Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.

G. Dallinga-Thie, R. Dullaart, R. de Vries, 2011, Atherosclerosis.

Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects.

B. Dahlbäck, L. Nielsen, R. Dullaart, 2011, Atherosclerosis.

Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects.

R. Dullaart, R. de Vries, P. J. Kappelle, 2012, Clinica chimica acta; international journal of clinical chemistry.

Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome.

G. Dallinga-Thie, R. Dullaart, P. J. Kappelle, 2010, Atherosclerosis.

Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

R. Dullaart, W. Annema, U. Tietge, 2012, European journal of clinical investigation.

Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

W. Sluiter, A. van Tol, R. Dullaart, 2010, Biochimica et biophysica acta.

Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.

G. Dallinga-Thie, R. Dullaart, P. J. Kappelle, 2010, Biochimica et biophysica acta.

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

W. Sluiter, M. Huisman, G. Dallinga-Thie, 2009, Expert opinion on therapeutic targets.

Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.

R. Dullaart, G. Lambert, Alexander Constantinides, 2012, Archives of medical research.